2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $166M | $212M | $257M | $187M | $268M |
Cost of Revenue | $155M | $204M | $262M | $185M | $268M |
Gross Profit | $11M | $7.9M | -$5.5M | $2M | -$580K |
Gross Profit % | 6.7% | 3.7% | -2.2% | 1.1% | -0.22% |
R&D Expenses | $213K | $88K | $180K | $152K | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$37M | -$47M | -$108M | -$46M | -$88M |
Dep. & Amort. | $4.9M | $5.5M | $5.6M | $7M | $8.4M |
Def. Tax | -$984K | $50K | $832K | -$750K | $0 |
Stock Comp. | $995K | $3.9M | $6.4M | $7.7M | $8.3M |
Chg. in WC | $25M | $5.4M | $6M | $14M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $592K | $7.8M | $4.3M | $2.7M | $898K |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $592K | $7.8M | $4.3M | $2.7M | $898K |
Receivables | $1.8M | $1.6M | $1.3M | $8.6M | $1.8M |
Inventory | $4M | $5.1M | $4.7M | $18M | $25M |
Aemetis reported revenues of $268 million for 2024, a significant increase from $187 million in 2023, driven by growth across all segments, including California ethanol, India biodiesel, and California renewable natural gas.
The company experienced a net loss of $87.5 million in 2024, compared to a net loss of $46.4 million in 2023, with increased costs and operating losses contributing to the decline.
Aemetis is optimistic about the impact of regulatory policies such as California's LCFS amendments, federal tax credits (45Z and 45Q), and E15 ethanol blend approvals, which are expected to drive future growth and profitability.
The company plans to expand its biogas production capacity to 1 million MMBtu per year by 2026 and is progressing on projects like the Riverbank SAF plant and carbon sequestration initiatives, supported by grants, tax credits, and USDA loans.
Aemetis is preparing for an IPO of its India biodiesel business, targeting late 2025 or early 2026, contingent on market conditions and renewed government support for biodiesel blending.